DK157168C - Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid - Google Patents

Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid

Info

Publication number
DK157168C
DK157168C DK424383A DK424383A DK157168C DK 157168 C DK157168 C DK 157168C DK 424383 A DK424383 A DK 424383A DK 424383 A DK424383 A DK 424383A DK 157168 C DK157168 C DK 157168C
Authority
DK
Denmark
Prior art keywords
diamindichloride
procedure
preparation
pharmaceutical preparations
preparations based
Prior art date
Application number
DK424383A
Other languages
Danish (da)
English (en)
Other versions
DK424383D0 (da
DK157168B (da
DK424383A (da
Inventor
Gaetano Battelli
Diego Oldani
Alessandro Rigamonti
Original Assignee
Erba Carlo Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Erba Carlo Spa filed Critical Erba Carlo Spa
Publication of DK424383D0 publication Critical patent/DK424383D0/da
Publication of DK424383A publication Critical patent/DK424383A/da
Publication of DK157168B publication Critical patent/DK157168B/da
Application granted granted Critical
Publication of DK157168C publication Critical patent/DK157168C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/24—Heavy metals; Compounds thereof
    • A61K33/243—Platinum; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK424383A 1982-09-23 1983-09-16 Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid DK157168C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT23396/82A IT1153974B (it) 1982-09-23 1982-09-23 Composizioni farmacologiche a base di cisplatino e metodo per il loro ottenimento
IT2339682 1982-09-23

Publications (4)

Publication Number Publication Date
DK424383D0 DK424383D0 (da) 1983-09-16
DK424383A DK424383A (da) 1984-03-24
DK157168B DK157168B (da) 1989-11-20
DK157168C true DK157168C (da) 1990-04-09

Family

ID=11206716

Family Applications (1)

Application Number Title Priority Date Filing Date
DK424383A DK157168C (da) 1982-09-23 1983-09-16 Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid

Country Status (20)

Country Link
US (1) US4670262A (enExample)
JP (1) JPS5978117A (enExample)
AT (1) AT382077B (enExample)
AU (1) AU559499B2 (enExample)
BE (1) BE897761A (enExample)
CA (1) CA1211372A (enExample)
CH (1) CH655852A5 (enExample)
DE (1) DE3333024A1 (enExample)
DK (1) DK157168C (enExample)
FI (1) FI78236C (enExample)
FR (1) FR2533439B1 (enExample)
GB (1) GB2127291B (enExample)
GR (1) GR79055B (enExample)
IE (1) IE56173B1 (enExample)
IL (1) IL69752A (enExample)
IT (1) IT1153974B (enExample)
NL (1) NL8303211A (enExample)
SE (1) SE464061B (enExample)
SU (1) SU1424722A3 (enExample)
ZA (1) ZA836904B (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8303657A (nl) * 1983-10-24 1985-05-17 Pharmachemie Bv Voor injectie geschikte, stabiele, waterige, zoutzuur bevattende oplossing van cisplatine, alsmede werkwijze ter bereiding daarvan.
IL76889A0 (en) * 1984-11-02 1986-02-28 Johnson Matthey Plc Solubilised platinum compound,method for the production thereof and pharmaceutical compositions containing the same
JPH0665648B2 (ja) * 1985-09-25 1994-08-24 塩野義製薬株式会社 白金系抗癌物質の安定な凍結真空乾燥製剤
JP2524217B2 (ja) * 1988-04-18 1996-08-14 マルハ株式会社 脳機能改善組成物、学習能力増強剤、記憶力増強剤、痴呆予防剤または痴呆治療剤
FI895340A7 (fi) * 1988-11-14 1990-05-15 Bristol Myers Squibb Co Hypertoninen cisplatin-liuos
US20030148933A1 (en) * 1990-10-01 2003-08-07 Pharma Mar S.A. Derivatives of dehydrodidemnin B
EP0620004B1 (en) * 1992-09-04 1998-11-25 Fuji Kagaku Kogyo Kabushiki Kaisha Medicinal composition
FR2759293B1 (fr) * 1997-02-11 1999-04-30 Ethypharm Lab Prod Ethiques Microgranules contenant du cisplatine, procede de fabrication, preparation pharmaceutique et utilisation en polychimiotherapie ou en association avec une radiotherapie
GB9803448D0 (en) * 1998-02-18 1998-04-15 Pharma Mar Sa Pharmaceutical formulation
WO2001035974A2 (en) * 1999-11-15 2001-05-25 Pharma Mar S.A. Aplidine treatment of cancers
UA76718C2 (uk) * 2000-06-30 2006-09-15 Фарма Мар, С.А. Протипухлинні похідні аплідину
NZ525196A (en) * 2000-10-12 2004-09-24 Pharma Mar S Treatment of cancers by aplidine in conjunction with a myoprotector
AU2002243646B2 (en) 2001-01-25 2006-06-22 The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Formulation of boronic acid compounds
RU2178702C1 (ru) * 2001-02-21 2002-01-27 Общество с ограниченной ответственностью "Нобель" Антираковое средство
CN1283242C (zh) * 2001-09-21 2006-11-08 大日本住友制药株式会社 冻干制剂
DE60229414D1 (de) * 2001-10-19 2008-11-27 Pharma Mar Sa Verwendung von aplidine in der behandlung von pankreaskrebs
DK1603584T3 (da) * 2003-03-12 2009-01-05 Dana Farber Cancer Inst Inc Aplidine til behandling af multipelt myelom
KR20060002778A (ko) * 2003-03-12 2006-01-09 파르마 마르, 에스.에이. 개선된 항종양 치료
ES2278115T3 (es) * 2003-10-13 2007-08-01 Zoser B. Nat.Rer.Dr. Salama Composicion farmaceutica que comprende oxoplatino y sus sales.
US8436190B2 (en) * 2005-01-14 2013-05-07 Cephalon, Inc. Bendamustine pharmaceutical compositions
DK2029155T3 (en) * 2006-02-28 2016-08-01 Pharma Mar Sa IMPROVED treatment of multiple myeloma
CA2703024A1 (en) * 2007-10-19 2009-04-23 Giuseppe Longo Sorbello Improved antitumoral treatments
MX2010009697A (es) * 2008-03-07 2010-09-30 Pharm Mar S A Tratamientos anticancerigenos mejorados.
AR072777A1 (es) 2008-03-26 2010-09-22 Cephalon Inc Formas solidas de clorhidrato de bendamustina
EP2889029A1 (en) 2008-09-25 2015-07-01 Cephalon, Inc. Liquid formulations of bendamustine
CN107773538B (zh) * 2016-08-27 2022-09-13 鲁南制药集团股份有限公司 稳定的甲啶铂无菌冻干粉末及其制备工艺
JOP20190254A1 (ar) 2017-04-27 2019-10-27 Pharma Mar Sa مركبات مضادة للأورام

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1432563A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum- co-ordination compounds
GB1432562A (en) * 1972-04-10 1976-04-22 Rustenburg Platinum Mines Ltd Platinum co-ordination compounds
US4053587A (en) * 1973-04-13 1977-10-11 Research Corporation Method of treating viral infections
US4255417A (en) * 1976-08-04 1981-03-10 Johnson Matthey, Inc. Platinum compounds for the irradication of skin blemishes
SE445172B (sv) * 1978-05-30 1986-06-09 Bristol Myers Co Stabil, steril vattenlosning av cisplatin i enhetsdoseringsform
US4273755A (en) * 1979-08-16 1981-06-16 Mpd Technology Corporation Preparation of platinum complexes
US4302446A (en) * 1979-10-02 1981-11-24 Bristol-Myers Company Pharmaceutical compositions
US4451447A (en) * 1980-03-31 1984-05-29 Bristol-Myers Company Pharmaceutical formulations
AU541056B2 (en) * 1980-03-31 1984-12-13 Bristol-Myers Company Pharmaceuticals formulations

Also Published As

Publication number Publication date
FR2533439B1 (fr) 1986-08-14
IL69752A (en) 1986-07-31
NL8303211A (nl) 1984-04-16
FI78236C (fi) 1989-07-10
AU1908983A (en) 1984-03-29
BE897761A (fr) 1984-01-02
SU1424722A3 (ru) 1988-09-15
FR2533439A1 (fr) 1984-03-30
SE8304920D0 (sv) 1983-09-13
FI833300A7 (fi) 1984-03-24
FI833300A0 (fi) 1983-09-15
IE832172L (en) 1984-03-23
IL69752A0 (en) 1983-12-30
DK424383D0 (da) 1983-09-16
DE3333024A1 (de) 1984-03-29
IE56173B1 (en) 1991-05-08
CH655852A5 (de) 1986-05-30
GB2127291B (en) 1986-01-15
US4670262A (en) 1987-06-02
AT382077B (de) 1987-01-12
DK157168B (da) 1989-11-20
AU559499B2 (en) 1987-03-12
IT8223396A0 (it) 1982-09-23
SE8304920L (sv) 1984-03-24
SE464061B (sv) 1991-03-04
IT1153974B (it) 1987-01-21
DK424383A (da) 1984-03-24
GR79055B (enExample) 1984-10-02
ATA326283A (de) 1986-06-15
ZA836904B (en) 1984-10-31
GB8324380D0 (en) 1983-10-12
JPS5978117A (ja) 1984-05-04
GB2127291A (en) 1984-04-11
CA1211372A (en) 1986-09-16
FI78236B (fi) 1989-03-31

Similar Documents

Publication Publication Date Title
DK157168C (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater paa basis af cis-platin(ii)-diamindichlorid
DK460283A (da) Fremgangsmaade til fremstilling af topiske farmaceutiske praeparater
DK1183D0 (da) Fremgangsmade til fremstilling af tiazolidinderivater
DK301383A (da) Fremgangsmaade til fremstilling af imidazolderivater
DK241883A (da) Fremgangsmaade til fremstilling af 1-sulfo-2-oxoazetidinderivater
DK280282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater indeholdende ergotalkaloider
DK372283D0 (da) Fremgangsmade til fremstilling af desoxyuridinderivater
DK149899C (da) Fremgangsmaade til fremstilling af termohaerdelige formstoffer paa basis af n,n'-diphenylen-bis-maleimider
DK127482A (da) Fremgangsmaade til fremstilling af dipeptidforbindelser
DK51282A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK309783D0 (da) Fremgangsmade til fremstilling af organoglykosider
DK119083D0 (da) Fremgangsmade til fremstilling af alkanoylpyridinoner
DK261883A (da) Fremgangsmaade til fremstilling af prostaglandin-d-derivater
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK317283A (da) Fremgangsmaade til fremstilling af thiadiazolderivater
DK296383D0 (da) Fremgangsmade til fremstilling af fenaetylaminer
DK424083A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK34888D0 (da) Fremgangsmaade til fremstilling af n,n-(dibenzohexatrienylen)urinstoffer
DK185683D0 (da) Fremgangsmade til fremstilling af pleuromutilinderivater
DK165583A (da) Fremgangsmaade til fremstilling af furanderivater
DK47681A (da) Fremgangsmaade til fremstilling af farmaceutiske praeparater
DK475783D0 (da) Fremgangsmade til fremstilling af farmaceutiske praeparater
DK20983A (da) Fremgangsmaade til fremstilling af indolinderivater
DK236683D0 (da) Fremgangsmade til fremstilling af trifenylbutenderivater
DK219483A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider

Legal Events

Date Code Title Description
PBP Patent lapsed